期刊文献+

HER2及EGFR蛋白在胃癌组织中的表达及临床价值 被引量:7

Expression of HER2 and EGFR protein and their clinical value in gastric carcinoma
暂未订购
导出
摘要 目的探讨胃癌组织中HER2和EGFR蛋白的表达及其与常见临床病理参数之间的关系,以及HER2和EGFR之间的相关性。方法应用免疫组织化学法检测胃癌组织标本中HER2和EGFR蛋白的表达情况,分析其表达与临床病理特征的关系。结果与癌旁正常组织比,胃癌组织标本中HER2和EGFR蛋白表达显著增加(P<0.01);不同分化程度、浸润深度、淋巴结转移和TNM分期的癌组织中HER2和EGFR的表达差异显著(P<0.05,P<0.01);胃癌组织中HER2与EGFR蛋白表达呈正相关关系(P<0.01)。结论胃癌组织阳性表达HER2和EGFR蛋白;HER2和EGFR联合表达对胃癌的进展可能有协同作用;测定HER2及EGFR蛋白在胃癌组织的表达为分子靶向治疗提供了理论依据;。 Objective To study the expression status of HER2 and epidermal growth factor receptor(EGFR) in gastric carcinoma and their association with clinical pathologic characteristics.Methods The expression of HER2 and EGFR in specimens of gastric carcinoma tissues was detected with immunohistochemical method;the correlation of HER2 and EGFR expression and the clinical pathologic characteristics was statistically processed.Results Positive expression of HER2 and EGFR existed in gastric carcinoma ti-ssues in comparison to the normal tissue around the tumor tissue(P0.01).The expression of HER2 and EGFR genes was statistically associated with the grades of differentiation,invasion depth,lymphatic metastasis and TNM stage of tumor tissues(P0.05,P0.01)and the positive correlation between the two protein expression appeared in gastric tumor tissue.Conclusion Gastric carcinoma cell expresses HER2 and EGFR proteins positively;they could serve as the significant biological markers of the prognosis of gastric carcinoma and a theory foundation of molecular target for gastric carcinoma therapy.
出处 《白求恩军医学院学报》 2011年第4期249-251,F0004,共4页 Journal of Bethune Military Medical College
关键词 胃癌 HER2 EGFR Gastric carcinoma HER2 Epidermal growth factor receptor
  • 相关文献

参考文献5

  • 1陈斌,罗荣城,崔斐,钱新宇.胃癌HER-2/neu基因表达与预后的相关性[J].南方医科大学学报,2006,26(3):344-347. 被引量:45
  • 2Rebischung C, Barnoud R, Stefani L, et al. The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein[ J]. Gastric Cancer,2005,8(4) :249-252.
  • 3Kopp R, Ruge M, Rothbauer E, et al. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gas- tric cancer patients [ J ]. Anticancer Res, 2002,22 ( 2B ) : 1161- 1167.
  • 4Van Cutsem E,Kang Y, Chung H, et al. Efective results fi'om the ToGA trial: a phase lII study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor re- ceptor 2 ( HER2)-positive advanced gastric cancer (GC) [ J ]. J Clin Oncol ( Meeting Abstracts), 2009,27 ( 18 S ) : 4509.
  • 5Pinto C ,Di Fabio F,Siena S, et al. Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma ( FOLCETUX study) [ J ]. Annals of oncology: official journal of the European So- ciety for Medical Oncology/ESMO,2007,18(3) :510-517.

二级参考文献15

  • 1李宁 祝庆孚.C-erbB-2和P53基因产物增强表达与胃癌生物学行为和预后关系[J].中华外科杂志,1994,32(9):558-558.
  • 2Schechter AL, Hung MC, Vaidyanathan L. The neu gene: an erbB-homologous gene distinct from and unlinked to. the gene encoding the EGF receptor[J]. Science, 1985, 229(4717): 976-8.
  • 3Sugano K, Ushiama M, Fulentomi T, et al. Combined measurement of the c-erbBo2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse [J]. Int J Cancer, 2000, 20, 89(4): 329-36.
  • 4Stahl P, Kissau L, Mazitschek R, et al. Total synthesis and biological evaluation of the nakijiquinones [J]. Am Chem Soc, 2001, 123(47): 11586-93.
  • 5Potti A, Ganti AK, Koch M, et al. Identification of HER-2/neu over-expression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia[J]. Lung Cancer, 2001, 34(2):227-32.
  • 6Delektorskaya W, Perevoshchikov AG, Kushlinskii NE. Immuno-histological study of NM 23 and C-erbB-2 expression in primary tumor and metastases of colorectal adenocarcinoma [J]. Bull Exp Biol Med, 2003, 135(5): 489-94.
  • 7Orr MS, O'Connor PM, Kohn KW. Effects of c-erbB-2 overexpression on the drug sensitivities of normal human mammary epithelial cells[J]. J Nat Cancer Inst, 2000, 92(12): 987-94.
  • 8Oya M, Yao T, Tsuneyoshi M. Expressions of cell cycle regulatory gene products in conventional gastric adenomas: possible immunohistochemical markers of malignant transformation [J].Hum Pathol,2000, 31 (3): 279-87.
  • 9Tokunaga A, Onda M, Okada T, et al. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2/n human gastric cancer[J]. Cancer, 1995, 75(6): 1418-25.
  • 10Ross JS, McKenna BJ .The HER-2/neu oncogene in tumors of the gastrointestinal tract[J]. Cancer Invest, 2001, 19(5): 554-68.

共引文献44

同被引文献61

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部